This prospective, randomized, double-blind, placebo-controlled study evaluated the
antiemetic efficacy of preoperative oral
ondansetron, 0.075 mg/kg or 0.15 mg/kg, in 136 preadolescent children premedicated with
midazolam 0.5 mg/kg per os and
dexamethasone 0.1 mg/kg intravenously prior to undergoing
tonsillectomy with
isoflurane anesthesia. The incidence of
vomiting during the 24 h after
tonsillectomy was significantly reduced (P < 0.04) by
ondansetron 0.15 mg/kg compared with placebo and
ondansetron 0.075 mg/kg (15%, 38%, and 36%, respectively). There was a significant reduction (P < 0.03) in the mean number of
vomiting episodes per patient during the 24 h immediately after
tonsillectomy in the
ondansetron 0.15 mg/kg group compared with the placebo and
ondansetron 0.075 mg/kg study groups (0.2 +/- 0.6, 0.8 +/- 1.3, and 0.8 +/- 1.3, respectively). The need for
antiemetic rescue
therapy (
ondansetron 0.15 mg/kg intravenously after three episodes of
emesis prior to discharge) was significantly greater in children who received placebo compared with the
ondansetron 0.15 mg/kg study group (13% vs 0%, P < 0.05). We conclude that
ondansetron 0.15 mg/kg, administered orally prior to
tonsillectomy, is associated with reduced
postoperative vomiting in preadolescent children. In addition, the preoperative
oral administration of
ondansetron 0.075 mg/kg is no more effective than placebo in preventing posttonsillectomy
vomiting in preadolescent children.